Comparison Pregnancy Outcomes Between Minimal Stimulation Protocol and Conventional GnRH Antagonist Protocols in Poor Ovarian Responders
Pilehvari، Shamim نويسنده Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran Pilehvari, Shamim , Shahrokh Tehraninejad، Ensieh نويسنده , , Hosseinrashidi، Batool نويسنده Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran Hosseinrashidi, Batool , Keikhah، Fatemeh نويسنده Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran Keikhah, Fatemeh , Haghollahi، Fedyeh نويسنده Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran , , Aziminekoo، Elham نويسنده Department of Obstetrics and Gynecology, Tehran University of Medical Sciences, Tehran, Iran ,
Objective: To compare the pregnancy outcomes achieved by in vitro fertilization (IVF) between minimal stimulation and conventional antagonist protocols in poor ovarian responders (PORs).
Materials and methods: In this randomized controlled trial, 77 PORs undergoing IVF were selected and divided into two groups. First group was the minimal stimulation group (n = 42) receiving 100 mg/day clomiphene citrate on day 2of the cycle for 5 day that was followed by150IU/day human menopausal gonadotropin (hMG) on day 5 of the cycle. Second group was the conventional group (n = 35) receiving at least 300 IU/daygonadotropin on day 2 of the cycle. Gonadotropin-releasing hormone (GnRH) antagonist protocol was applied for both groups according to flexible protocol. Number of retrieved oocytes and chemical pregnancy rate were the main outcomes.
Results: There was no difference in number ofretrieved oocyte and pregnancy rate (2.79 ± 1.96 vs. 2.20 ± 1.71 and 5.6% vs. 4.1%; p > 0.05) between both groups. The gonadotropin dose used in the minimal stimulation group was lower than conventional group (1046 ± 596 vs. 2806 ± 583).
Conclusion: Minimal stimulation protocol with lower gonadotropin used is likely to be considered as a patient- friendly and cost-effective substitute for PORs.